Related Experiment Video
Updated: Jan 3, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis
Yuchong Peng1,2, Youhong Liu1,2, Yingxue Gao1,2
1Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Background:
The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to target USP7. However, the anticancer mechanism of USP7 inhibitors is still elusive.
Methods:
Cell viability or clonogenicity was tested by violet crystal assay. Cell apoptosis or cell cycle was analyzed by flow cytometry, and chromosome misalignment was observed by a fluorescent microscopy. The protein interaction of PLK1 and USP7 was detected by tandem affinity purification and high throughput proteomics, and further confirmed by co-immunoprecipitation, GST pull-down and protein co-localization. The correlation between USP7 level of tumor tissues and taxane-resistance was evaluated.
Results:
Pharmacological USP7 inhibition by P5091 retarded cell proliferation and induced cell apoptosis. Further studies showed that P5091 induced cell cycle arrest at G2/M phase, and particularly induced chromosome misalignment, indicating the key roles of USP7 in mitosis. USP7 protein was detected in the PLK1-interacted protein complex. USP7 interacts with PLK1 protein through its PBD domain by catalytic activity. USP7 as a deubiquitinase sustained PLK1 protein stability via the C223 site, and inversely, USP7 inhibition by P5091 promoted the protein degradation of PLK1 through the ubiquitination-proteasome pathway. By overexpressing PLK1, USP7 that had been depleted by RNAi ceased to induce chromosome misalignment in mitosis and again supported cell proliferation and cell survival. Both USP7 and PLK1 were overexpressed in taxane-resistant cancer cells, and negatively correlated with the MP scores in tumor tissues. Either USP7 or PLK1 knockdown by RNAi significantly sensitized taxane-resistant cells to taxane cell killing.
Conclusion:
This is the first report that PLK1 is a novel substrate of USP7 deubiquitinase, and that USP7 sustained the protein stability of PLK1. USP7 inhibition induces cell apoptosis and cell cycle G2/M arrest, and overcomes taxane resistance by inducing the protein degradation of PLK1, resulting in chromosome misalignment in mitosis.
Insights
USP7 inhibition by P5091 induces cancer cell apoptosis and overcomes taxane resistance by degrading PLK1, leading to mitotic errors. This study identifies PLK1 as a USP7 substrate, revealing a novel anticancer mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- USP7 (deubiquitinase) is an oncogene implicated in tumorigenesis and therapeutic resistance.
- Small molecule inhibitors targeting USP7 have been developed, but their anticancer mechanisms remain unclear.
Purpose of the Study:
- To elucidate the anticancer mechanism of USP7 inhibitors.
- To investigate the role of USP7 in mitosis and its relationship with taxane resistance.
Main Methods:
- Cell viability, apoptosis, and cell cycle analyzed by crystal violet assay and flow cytometry.
- Chromosome misalignment observed via fluorescent microscopy.
- Protein interactions (USP7-PLK1) confirmed using tandem affinity purification, proteomics, co-immunoprecipitation, and GST pull-down assays.
- Correlation between USP7 levels and taxane resistance in tumor tissues evaluated.
Main Results:
- USP7 inhibition by P5091 reduced cell proliferation, induced apoptosis, and caused G2/M cell cycle arrest with chromosome misalignment.
- USP7 directly interacts with and stabilizes PLK1 protein; P5091 treatment promotes PLK1 degradation via ubiquitination.
- Overexpression of PLK1 rescued USP7 depletion-induced mitotic errors, proliferation inhibition, and cell death.
- USP7 and PLK1 are overexpressed in taxane-resistant cancers; their knockdown sensitizes cells to taxane treatment.
Conclusions:
- PLK1 is a novel substrate of USP7, which maintains PLK1 protein stability.
- USP7 inhibition leads to PLK1 degradation, causing mitotic errors (chromosome misalignment), apoptosis, and cell cycle arrest.
- Targeting USP7 overcomes taxane resistance by disrupting the USP7-PLK1 interaction, offering a potential therapeutic strategy.
More Related Videos
09:45Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
12:28Protein Purification Technique that Allows Detection of Sumoylation and Ubiquitination of Budding Yeast Kinetochore Proteins Ndc10 and Ndc80
Published on: May 3, 2015
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation